Vineeta Belanger
Chief Tech/Sci/R&D Officer bij LYRA THERAPEUTICS, INC.
Profiel
Dr. Vineeta Belanger is a Senior Vice President-Clinical Affairs at Lyra Therapeutics, Inc. Dr. Belanger was previously employed as a Vice President-Clinical Affairs by Avedro, Inc. and a Principal by Ironwood Pharmaceuticals, Inc. She received her undergraduate degree from All India Institute of Medical Sciences and a doctorate degree from the University of Houston.
Actieve functies van Vineeta Belanger
| Bedrijven | Functie | Begin |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-09-2019 |
Eerdere bekende functies van Vineeta Belanger
| Bedrijven | Functie | Einde |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AVEDRO, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Vineeta Belanger
| University of Houston | Doctorate Degree |
| All India Institute of Medical Sciences | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
